Gender bias plays a significant role in making fibromyalgia invisible among men. Diagnosis is more frequent in women, meaning male patients are under-represented in clinical studies and diagnoses.
Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...
TNX-102 SL, a sublingual cyclobenzaprine HCl formulation, is safe and effective for treating fibromyalgia symptoms, according to study results presented at the American College of Rheumatology (ACR) ...
Fibromyalgia, a long-term pain condition, impacts millions of people worldwide, commonly causing muscle pain and stiffness. These symptoms can sometimes be so intense that they disable affected ...
Investors interested in arranging a meeting with the Company’s management virtually during the conference should contact the Investor Summit conference coordinator. A live webcast of the presentation ...
The following is a summary of “Plasma neurofilament light chain in fibromyalgia: A case control study exploring correlation with clinical and cognitive features,” published in the November 2024 issue ...
(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the ACR Convergence 2024 Annual Meeting showcasing the success of its Phase 3 RESILIENT study for TNX-102 SL, a ...